175 related articles for article (PubMed ID: 20960062)
1. Drug salts and solubilization: modeling the influence of cyclodextrins on oral absorption.
Gamsiz ED; Thombre AG; Ahmed I; Carrier RL
Ann Biomed Eng; 2011 Jan; 39(1):455-68. PubMed ID: 20960062
[TBL] [Abstract][Full Text] [Related]
2. Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development.
Gamsiz ED; Miller L; Thombre AG; Ahmed I; Carrier RL
Biotechnol Bioeng; 2010 Feb; 105(2):409-20. PubMed ID: 19725042
[TBL] [Abstract][Full Text] [Related]
3. Model predicting impact of complexation with cyclodextrins on oral absorption.
Gamsiz ED; Thombre AG; Ahmed I; Carrier RL
Biotechnol Bioeng; 2013 Sep; 110(9):2536-47. PubMed ID: 23592239
[TBL] [Abstract][Full Text] [Related]
4. Modeling the influence of cyclodextrins on oral absorption of low solubility drugs: II. Experimental validation.
Gamsiz ED; Miller L; Thombre AG; Ahmed I; Carrier RL
Biotechnol Bioeng; 2010 Feb; 105(2):421-30. PubMed ID: 19725043
[TBL] [Abstract][Full Text] [Related]
5. The utility of cyclodextrins for enhancing oral bioavailability.
Carrier RL; Miller LA; Ahmed I
J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
[TBL] [Abstract][Full Text] [Related]
6. Preparation and cyclodextrin assisted dissolution rate enhancement of itraconazolium dinitrate salt.
Kumar N; Shishu ; Bansal G; Kumar S; Jana AK
Drug Dev Ind Pharm; 2013 Feb; 39(2):342-51. PubMed ID: 22553909
[TBL] [Abstract][Full Text] [Related]
7. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
8. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
9. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
10. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
Stojanov M; Nielsen HM; Larsen KL
Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations.
Williams HD; Ford L; Han S; Tangso KJ; Lim S; Shackleford DM; Vodak DT; Benameur H; Pouton CW; Scammells PJ; Porter CJH
Mol Pharm; 2018 Dec; 15(12):5678-5696. PubMed ID: 30376336
[TBL] [Abstract][Full Text] [Related]
12. Modulation of release rate and barrier transport of Diclofenac incorporated in hydrophilic matrices: role of cyclodextrins and implications in oral drug delivery.
Miro A; Rondinone A; Nappi A; Ungaro F; Quaglia F; La Rotonda MI
Eur J Pharm Biopharm; 2009 May; 72(1):76-82. PubMed ID: 19135532
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of the effect of supersaturation on in vivo drug absorption.
Takano R; Takata N; Saito R; Furumoto K; Higo S; Hayashi Y; Machida M; Aso Y; Yamashita S
Mol Pharm; 2010 Oct; 7(5):1431-40. PubMed ID: 20704264
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
15. Cyclodextrins and chitosan derivatives in sublingual delivery of low solubility peptides: A study using cyclosporin A, alpha-cyclodextrin and quaternary chitosan N-betainate.
Mannila J; Järvinen K; Holappa J; Matilainen L; Auriola S; Jarho P
Int J Pharm; 2009 Oct; 381(1):19-24. PubMed ID: 19632311
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin.
Sridevi S; Chauhan AS; Chalasani KB; Jain AK; Diwan PV
Pharmazie; 2003 Nov; 58(11):807-10. PubMed ID: 14664337
[TBL] [Abstract][Full Text] [Related]
17. Influence of cyclodextrin complexation on piroxicam gel formulations.
Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Free Drug Absorption in Cyclodextrin Formulation by a Modified Physiologically Based Pharmacokinetic Model and Phase Solubility 3-D Surface Graph.
Wang W; Ouyang D
Pharm Res; 2021 Jul; 38(7):1157-1168. PubMed ID: 34145531
[TBL] [Abstract][Full Text] [Related]
19. Enabling superior drug loading in lipid-based formulations with lipophilic salts for a brick dust molecule: Exploration of lipophilic counterions and in vitro-in vivo evaluation.
Sirvi A; Jadhav K; Sangamwar AT
Int J Pharm; 2024 May; 656():124108. PubMed ID: 38604540
[TBL] [Abstract][Full Text] [Related]
20. Aggregation of cyclodextrins as an important factor to determine their complexation behavior.
Bikádi Z; Kurdi R; Balogh S; Szemán J; Hazai E
Chem Biodivers; 2006 Nov; 3(11):1266-78. PubMed ID: 17193241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]